Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
Chief of the Bacterial Diseases Branch, Division of Vector-Borne Diseases at the Centers for Disease Control & Prevention, walks us through a growing health problem in the United States, tickborne diseases.
One in eight adults (12.7%) who are infected with SARS-CoV-2 experience long COVID symptoms, including chest pain, difficulties breathing, painful muscles and more.
South Korea's leading molecular diagnostics (MDx) company Seegene Inc. has developed a PCR to detect positive cases of monkeypox virus within 90 minutes.
Gaspary Mwanyika from the SACIDS Foundation for One Health, Sokoine University of Agriculture, Tanzania details the importance of genomic characterisation in the control of dengue.
Empowering employees and examining emerging health threats in a new strategy for business growth is Novacyt CEO David Allmond’s mission in the weeks ahead.
This ‘unusual’ monkeypox outbreak has been found to be larger and more widespread than previous outbreaks outside of Africa, and health experts propose better preparation.
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
